


Healthcare Industry News: HR+/HER2
News Release - July 5, 2024
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
Source: Biostar Pharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
